Advertisement

Picture [LSG] Life-Sciences-Germany.com – The Business Web Portal 600x80px
Document › Details

Danaher Corporation. (11/4/16). "Press Release: Danaher Completes Acquisition of Cepheid". Washington, DC.

Organisations Organisation Danaher Corporation (NYSE: DHR)
  Group Danaher (Group)
  Organisation 2 Cepheid (US) (Nasdaq: CPHD)
  Group Danaher (Group)
Products Product molecular diagnostics
  Product 2 analytical instrument
Index term Index term Cepheid–Danaher: investment, 201609–201611 acquisition cash tender offer $53/share valuing Cepheid at $4b net of debt + cash
Person Person Gugino, Matthew E. (Danaher 201407 VP Investor Relations)
     


Danaher Corporation (NYSE: DHR) ("Danaher") announced that today it completed its acquisition of Cepheid (NASDAQ: CPHD).

Copper Merger Sub, Inc. ("Copper"), a California corporation and an indirect wholly owned subsidiary of Danaher, has merged into Cepheid and, as a result, Cepheid has become an indirect wholly owned subsidiary of Danaher. In the merger, each outstanding share of Cepheid common stock was cancelled and (except for shares held by Danaher, Copper, Cepheid and their respective subsidiaries) converted into the right to receive $53.00 per share in cash, without interest.

Cepheid's common stock will cease to be traded on the Nasdaq Stock Market. Detailed instructions will be sent to former Cepheid shareholders outlining the steps to be taken to obtain the merger consideration of $53.00 per share in cash, without interest.


ABOUT DANAHER

Danaher is a global science and technology innovator committed to helping its customers solve complex challenges and improving quality of life around the world. Its family of world class brands has leadership positions in some of the most demanding and attractive industries, including health care, environmental and industrial. With more than 20 operating companies, Danaher's globally diverse team of 59,000 associates is united by a common culture and operating system, the Danaher Business System. For more information please visit www.danaher.com.


CONTACT

Matthew E. Gugino
Vice President, Investor Relations
Danaher Corporation
2200 Pennsylvania Avenue, N.W., Suite 800W
Washington, D.C. 20037
Telephone: (202) 828-0850
Fax: (202) 828-0860


FOR THOSE CEPHEID SHAREHOLDERS WHO NEED INFORMATION ABOUT RECEIVING THEIR MERGER CONSIDERATION, CONTACT

Computershare, Inc.
Toll Free: (800) 568-3476
Outside the U.S.: +1-312-588-4991

   
Record changed: 2016-12-23

Advertisement

Picture [LSUK] Life-Sciences-UK.com – The Business Web Portal 600x80px

More documents for Danaher (Group)


To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to info@iito.de and simply fill the subject line with the word »MSC newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at Life-Sciences-Germany.com and Life-Sciences-Europe.com

Advertisement

Picture EBD Group Biotech Showcase 2018 BTS San Francisco January 600x60px




» top

Advertisements

Picture [iito] Twitter iitoLifeScience Life Sciences Mass Spec 120x120px Picture EBD Group Biotech Showcase 2018 BTS San Francisco January 120x180px Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 120x600px Banner Fairtec GmbH Solutions for Smarter Business Events Exhibitions 120x120px Picture [iito] Twitter iitoLifeScience Life Sciences Mass Spec 120x120px Picture EBD Group Biotech Showcase 2018 BTS San Francisco January 120x180px